Medtronic | MDT - Operating Profit



Medtronic reported $1.52B in Operating Profit for its fiscal quarter ending in July of 2025.


Operating Profit Change Date
Abbott USD 2.07B 415M Jun/2025
AtriCure USD -3820000 2.13M Jun/2025
Baxter International USD 272M 214M Jun/2025
Becton, Dickinson and Co. USD 979M 433M Jun/2025
Boston Scientific USD 942M 21M Jun/2025
Cooper Companies USD 175.7M 9.1M Jul/2025
Danaher USD 760M 523M Jun/2025
Dexcom USD 212.6M 78.9M Jun/2025
Edwards Lifesciences USD 430.9M 36.1M Jun/2025
Globus Medical USD -125953000 222.96M Jun/2025
Hologic USD 260.9M 267.9M Jun/2025
Insulet USD 121.1M 71.8M Jun/2025
Integra LifeSciences USD -1309000 14.65M Jun/2025
Intuitive Surgical USD 746.9M 168.8M Jun/2025
J&J USD 6.94B 6.69B Jun/2025
Masimo USD 64.5M 13.5M Jun/2025
Medtronic USD 1.52B 81M Jul/2025
Merit Medical Systems USD 47.02M 5.99M Jun/2025
Philips EUR 488M 334M Jun/2025
Smith & Nephew USD 440M 111M Jun/2025
Stryker USD 1.17B 331M Jun/2025
Tandem Diabetes Care USD -31859000 89.02M Jun/2025
Teleflex USD 177.48M 47.16M Jun/2025
Terumo JPY 55.89B 31.71B Jun/2025
Thermo Fisher Scientific USD 1.92B 200M Jun/2025
Zimmer Biomet Holdings USD 396.4M 57.5M Jun/2025